Home Newsfeeds Susquehanna Maintains Negative on Intel, Raises Price Target to $24

Susquehanna Maintains Negative on Intel, Raises Price Target to $24

Susquehanna analyst Christopher Rolland maintains Intel (NASDAQ:INTC) with a Negative and raises the price target from $22 to $24.

byBenzinga Newsdesk

January 23, 2023

1 minute read

Susquehanna analyst Christopher Rolland maintains Intel (NASDAQ:INTC) with a Negative and raises the price target from $22 to $24.

Adamis Pharma Shares Nosedive As Its COVID-19 Candidate Shows No Efficacy

By Vandana Singh

September 21, 9:58 AM

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced the results from the third planned interim analysis of the Phase 2/3 clinical trial of Tempol in high-risk subjects with early COVID-19 infection.

ADMP

What’s Going On With AMD Stock Monday?

By Anusuya Lahiri

November 6, 11:44 AM

Advanced Micro Devices, Inc (NASDAQ: AMD) has been hitting the headlines as one of the most potent rivals of artificial intelligence kingpin Nvidia Corp (NASDAQ: NVDA).

AAPL

Worried Apple Vision Pro’s Wi-Fi And Bluetooth Could ‘Cook’ Your Brain? Here’s What You Should Know

By Rounak Jain

February 12, 10:29 AM

Apple Vision Pro comes with Wi-Fi and Bluetooth connectivity support, and some users might have concerns about radio frequency (RF) radiation since it is worn on the face.

AAPL

Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected

By Rolando García

June 13, 3:29 PM

Discover how Anson Funds settled with the SEC for $2.25M over an undisclosed collaboration with short seller impacting cannabis stocks

IGC

Susquehanna Maintains Negative on Intel, Raises Price Target to $24

Related Posts

Adamis Pharma Shares Nosedive As Its COVID-19 Candidate Shows No Efficacy

What’s Going On With AMD Stock Monday?

Worried Apple Vision Pro’s Wi-Fi And Bluetooth Could ‘Cook’ Your Brain? Here’s What You Should Know

Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected